" class="no-js "lang="en-US"> Parkinson's Disease Archives - Medtech Alert
Sunday, March 03, 2024

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

The University of Oxford and Selvita Collaborate to Advance Potential Therapeutics for Parkinson's Disease

The University of Oxford and Selvita, one of the largest contract research organizations in Europe, […]

HanAll Biopharma and Daewoong Pharmaceutical Enter into Co-Development Agreement with NurrOn Pharmaceuticals to Develop Therapy for Parkinson's Disease

HanAll Biopharma and Daewoong Pharmaceutical announced that they have entered into a co-development agreement with NurrOn […]

Verana Health Announces the Qdata Parkinson's Disease Module at 2023 AAN Annual Meeting

Verana Health, a digital health company elevating quality in real-world data (RWD), has announced it’s […]

AskBio to Present Phase 1b Results Investigating AB-1005 as Treatment for Parkinson's Disease

Asklepios BioPharmaceutical (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary […]

BlueRock Therapeutics to use Rune Labs' Clinical Trial Platform to Better Characterize Parkinson's Disease State in Cell Therapy Trials

Rune Labs, a precision neurology software and data platform company, today announced a partnership with […]

Celltrion and LISCure Biosciences Announce Strategic Collaboration to Develop Novel Microbiome Treatment for Parkinson's Disease

LISCure Biosciences, a clinical-stage biotech developing advanced microbiome technology with precision targets, announced a multi-year […]

Ryne Biotechnology Awarded $4 Million from the California Institute for Regenerative Medicine

Ryne Biotechnology, a therapeutics company leveraging induced pluripotent stem cell (iPSC) technology to discover and […]

MedRhythms Feasibility Study Shows Positive Topline Results in Parkinson's Disease

MedRhythms announced the successful completion of a multi-site feasibility study of MR-005, its investigational asset […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more